Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

HTLV-I infection: a dynamic struggle between viral persistence and host immunity.

Lim AG, Maini PK.

J Theor Biol. 2014 Jul 7;352:92-108. doi: 10.1016/j.jtbi.2014.02.022. Epub 2014 Feb 28.

PMID:
24583256
2.

Modelling the role of Tax expression in HTLV-I persistence in vivo.

Li MY, Lim AG.

Bull Math Biol. 2011 Dec;73(12):3008-29. doi: 10.1007/s11538-011-9657-1. Epub 2011 Apr 21.

PMID:
21509627
3.

How does HTLV-I persist despite a strong cell-mediated immune response?

Asquith B, Bangham CR.

Trends Immunol. 2008 Jan;29(1):4-11. Epub 2007 Nov 26.

PMID:
18042431
4.
5.

Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I.

Bangham CR, Hall SE, Jeffery KJ, Vine AM, Witkover A, Nowak MA, Wodarz D, Usuku K, Osame M.

Philos Trans R Soc Lond B Biol Sci. 1999 Apr 29;354(1384):691-700. Review.

6.
7.

Double control systems for human T-cell leukemia virus type 1 by innate and acquired immunity.

Kannagi M, Hasegawa A, Kinpara S, Shimizu Y, Takamori A, Utsunomiya A.

Cancer Sci. 2011 Apr;102(4):670-6. doi: 10.1111/j.1349-7006.2011.01862.x. Epub 2011 Feb 28. Review.

8.

The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1.

Vine AM, Heaps AG, Kaftantzi L, Mosley A, Asquith B, Witkover A, Thompson G, Saito M, Goon PK, Carr L, Martinez-Murillo F, Taylor GP, Bangham CR.

J Immunol. 2004 Oct 15;173(8):5121-9.

9.

Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.

de Souza JG, da Fonseca FG, Martins ML, Martins CP, de Carvalho LD, Coelho-dos-Reis JG, Carneiro-Proietti AB, Martins-Filho OA, Barbosa-Stancioli EF; GIPH.

J Clin Virol. 2011 Jan;50(1):13-8. doi: 10.1016/j.jcv.2010.09.007. Epub 2010 Oct 15.

PMID:
20951636
10.

Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.

Goon PK, Igakura T, Hanon E, Mosley AJ, Barfield A, Barnard AL, Kaftantzi L, Tanaka Y, Taylor GP, Weber JN, Bangham CR.

J Immunol. 2004 Feb 1;172(3):1735-43.

11.

Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration.

Barmak K, Harhaj E, Grant C, Alefantis T, Wigdahl B.

Virology. 2003 Mar 30;308(1):1-12. Review.

12.

Is human T-cell lymphotropic virus type I really silent?

Asquith B, Hanon E, Taylor GP, Bangham CR.

Philos Trans R Soc Lond B Biol Sci. 2000 Aug 29;355(1400):1013-9. Review.

13.

Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry.

Lee TH, Chafets DM, Busch MP, Murphy EL.

J Clin Virol. 2004 Dec;31(4):275-82.

PMID:
15494269
14.

HTLV-1 drives vigorous clonal expansion of infected CD8(+) T cells in natural infection.

Melamed A, Laydon DJ, Al Khatib H, Rowan AG, Taylor GP, Bangham CR.

Retrovirology. 2015 Nov 9;12:91. doi: 10.1186/s12977-015-0221-1.

15.

Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Höllsberg P.

Microbiol Mol Biol Rev. 1999 Jun;63(2):308-33. Review.

16.

Cytotoxic T cell response and expression of the target antigen in HTLV-I infection.

Kannagi M, Matsushita S, Shida H, Harada S.

Leukemia. 1994 Apr;8 Suppl 1:S54-9.

PMID:
8152305
17.

HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals.

Satou Y, Utsunomiya A, Tanabe J, Nakagawa M, Nosaka K, Matsuoka M.

Retrovirology. 2012 May 30;9:46. doi: 10.1186/1742-4690-9-46.

18.

[Anti-tumor immunity in adult T-cell leukemia].

Kannagi M.

Uirusu. 2004 Jun;54(1):67-74. Review. Japanese.

19.

Degenerate specificity of HTLV-1-specific CD8+ T cells during viral replication in patients with HTLV-1-associated myelopathy (HAM/TSP).

Kubota R, Furukawa Y, Izumo S, Usuku K, Osame M.

Blood. 2003 Apr 15;101(8):3074-81. Epub 2002 Dec 12.

20.

Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.

Tanaka Y, Yamazaki R, Terasako-Saito K, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Kimura S, Kikuchi M, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y.

Immunol Lett. 2014 Mar-Apr;158(1-2):120-5. doi: 10.1016/j.imlet.2013.12.016. Epub 2014 Jan 2.

PMID:
24389072

Supplemental Content

Support Center